Jerry Gurwitz to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Jerry Gurwitz has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
2.385
-
Singh S, Go AS, Wenger NK, Zoungas S, Gurwitz JH. Reply to: Statins for Primary Prevention in Older Adults. J Am Geriatr Soc. 2019 04; 67(4):857-858.
Score: 0.550
-
Singh S, Zieman S, Go AS, Fortmann SP, Wenger NK, Fleg JL, Radziszewska B, Stone NJ, Zoungas S, Gurwitz JH. Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making. J Am Geriatr Soc. 2018 11; 66(11):2188-2196.
Score: 0.538
-
Gurwitz JH, Go AS, Fortmann SP. Use of Statins in Adults Older Than 75 Years-Reply. JAMA. 2017 03 14; 317(10):1081.
Score: 0.483
-
Gurwitz JH, Go AS, Fortmann SP. Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence. JAMA. 2016 Nov 15; 316(19):1971-1972.
Score: 0.472
-
Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
Score: 0.235
-
Smith DH, Johnson ES, Boudreau DM, Cassidy-Bushrow AE, Fortmann SP, Greenlee RT, Gurwitz JH, Magid DJ, McNeal CJ, Reynolds K, Steinhubl SR, Thorp M, Tom JO, Vupputuri S, VanWormer JJ, Weinstein J, Yang X, Go AS, Sidney S. Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study. Am J Med. 2015 Nov; 128(11):1252.e1-1252.e11.
Score: 0.107